Cite Filings / VRDN / 0001193125-16-756092
Feed Companies Filings Check
Sign in
425

Prospectus/Communication re Business Combination

Viridian Therapeutics, Inc.\DE · Filed 2016-11-02 · Acc 0001193125-16-756092

Documents 1

  • 425 Prospectus/Communication re Business Combination , d286244d8k.htm

Around this filing

  • 2016-11-03 425 Prospectus/Communication re Business Combination
  • 2016-11-02 4 CFO, Secretary, Treasurer gave up 66,547 shares (to pay taxes)
  • 2016-11-02 4 President & CEO gave up 103,160 shares (to pay taxes)
  • 2016-11-02 425 Prospectus/Communication re Business Combination
  • 2016-11-02 8-K Other events
  • 2016-11-01 425 Prospectus/Communication re Business Combination
  • 2016-11-01 8-K Material agreement · Shareholder rights changed · Executive or director change · Bylaws or fiscal year change · Regulation FD disclosure · Other events

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading d286244d8k.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…